Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra(Inserm), Frédéric Bost(Inserm), Marcel Deckert(Inserm), Pierre Gounon(Institut Pasteur), Patrick Auberger(Inserm), Sandy Giuliano(Centre National de la Recherche Scientifique), Corine Bertolotto(Centre Méditerranéen de Médecine Moléculaire), Jean‐François Tanti(Inserm), Y. Le Marchand‐Brustel(Inserm), Mireille Cormont(Inserm), Frédéric Larbret(Inserm), Sophie Giorgetti‐Peraldi(Inserm), Kathiane Laurent(Inserm), Gilles Ponzio(Inserm)
Cited by 528
Related Papers
The stomach is a source of leptin
|Nature|1998|1.2k
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
|Biochimie|2004|892
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
|Oncogene|2008|852
Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
|Endocrinology|2006|677
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
|Cancer Research|2011|620